Cargando…
Normalizing sleep quality disturbed by psychiatric polypharmacy: a single patient open trial (SPOT)
There is a growing interest in personalized and preventive medicine initiatives that leverage serious patient engagement, such as those initiated and pursued among participants in the quantified-self movement. However, many of the self-assessments that result are not rooted in good scientific practi...
Autores principales: | Magnuson, Victoria, Wang, Yanpin, Schork, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527988/ https://www.ncbi.nlm.nih.gov/pubmed/28781744 http://dx.doi.org/10.12688/f1000research.7694.2 |
Ejemplares similares
-
Power and Design Issues in Crossover-Based N-Of-1 Clinical Trials with Fixed Data Collection Periods
por: Wang, Yanpin, et al.
Publicado: (2019) -
Sleep disturbances, psychiatric disorders, and psychotropic drugs
por: Staner, Luc
Publicado: (2005) -
Sleep disturbance and its association with quality of life among psychiatric nurses in China
por: Lu, Li, et al.
Publicado: (2021) -
Polypharmacy in psychiatric practice in the Canary Islands
por: De las Cuevas, Carlos, et al.
Publicado: (2004) -
An evaluation of sleep disturbance on in-patient psychiatric units in the UK
por: Horne, Sam, et al.
Publicado: (2018)